A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

NCT00661284 · clinicaltrials.gov ↗
COMPLETED
Status
189
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Chugai Pharmaceutical